Biotech stocks drop 10% on NIH funding cut fears by Q3 2026

Investors will react to the proposed NIH funding cuts by selling off biotech stocks, particularly those reliant on NIH grants. A 10% drop in the NYSE ARCA Biotechnology Index by the end of Q3 2026 would reflect market sentiment.

Implied probability (Yes)

68%